Founded in 1988, Medhold delivers medical devices, technology, and software across Southern Africa, including orthopaedic, diagnostic, theatre, intensive care, and robotic-assisted surgical systems.
With Sanlam Private Equity now at the helm, Medhold plans to expand its product portfolio, reach additional healthcare providers, and continue its focus on employee development and socially responsible initiatives.
These include training programs, learnerships, and donations to public healthcare facilities.
Motsepe’s firm drives growth and regional expansion
The deal follows a partnership with Old Mutual Private Equity (OMPE), which acquired a 50% stake in 2018 and supported Medhold’s expansion and operational strengthening. OMPE has now sold its interest to Sanlam Private Equity, giving Motsepe’s firm full majority control Business Tech reports
“As private equity investors, we know that we are uniquely placed to drive real economic change,” said Paul Moeketsi, Managing Partner at Sanlam Private Equity.
“The philosophy is simple: back resilient businesses that create sustainable value, while also strengthening the country’s social and economic fabric. Medhold is one such business.”
“Transactions such as this can help formalise, professionalise and scale mid-market companies, which are the backbone of the South African economy,” said Sanlam Private Equity Investment Principal Brandon Subrayan.
“This creates better-run businesses with strong governance structures, stronger supply chains, and more inclusive employment. It also fosters innovation in sectors like healthcare, technology, and education.”
Sanlam Private Equity’s involvement under Motsepe signals confidence in Southern Africa’s healthcare sector at a time when demand for advanced medical devices and services is growing. “We are looking forward to being a part of the transformation in healthcare and the innovation that will make a difference in South Africa, and beyond,” Subrayan added.
The acquisition highlights Motsepe’s strategic approach to private equity: investing in resilient companies like Medhold that can deliver both financial returns and social impact across the region.
